1834 Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Buy
85,346
+2,051
+2% +$237K 1.28% 20
2025
Q4
$8.77M Buy
83,295
+3,837
+5% +$360K 1.1% 22
2025
Q3
$6.67M Buy
79,458
+2,264
+3% +$186K 0.82% 37
2025
Q2
$6.11M Buy
77,194
+7,088
+10% +$563K 0.77% 42
2025
Q1
$6.29M Buy
70,106
+3,292
+5% +$307K 0.81% 37
2024
Q4
$6.65M Sell
66,814
-4,115
-6% -$424K 0.84% 33
2024
Q3
$8.05M Sell
70,929
-946
-1% -$112K 0.94% 29
2024
Q2
$8.9M Sell
71,875
-1,970
-3% -$254K 1.07% 19
2024
Q1
$9.74M Sell
73,845
-5,861
-7% -$722K 1.16% 17
2023
Q4
$8.69M Sell
79,706
-1,519
-2% -$158K 1.04% 24
2023
Q3
$8.36M Buy
81,225
+8,144
+11% +$878K 1.04% 23
2023
Q2
$8.43M Sell
73,081
-5,329
-7% -$605K 1% 26
2023
Q1
$8.34M Sell
78,410
-5,852
-7% -$632K 1% 28
2022
Q4
$9.35M Sell
84,262
-7,248
-8% -$741K 1.33% 19
2022
Q3
$7.88M Buy
91,510
+30,819
+51% +$2.75M 1.18% 26
2022
Q2
$5.53M Buy
60,691
+27,920
+85% +$2.48M 0.78% 44
2022
Q1
$2.69M Buy
32,771
+9,726
+42% +$767K 0.33% 67
2021
Q4
$1.77M Sell
23,045
-2,525
-10% -$201K 0.2% 82
2021
Q3
$1.92M Buy
25,570
+33
+0.1% +$2.51K 0.23% 84
2021
Q2
$1.99M Buy
25,537
+3,775
+17% +$281K 0.24% 83
2021
Q1
$1.6M Sell
21,762
-4,949
-19% -$365K 0.21% 84
2020
Q4
$2.08M Sell
26,711
-1,496
-5% -$114K 0.28% 70
2020
Q3
$2.23M Sell
28,207
-380
-1% -$29.8K 0.33% 65
2020
Q2
$2.11M Buy
28,587
+8,029
+39% +$604K 0.33% 64
2020
Q1
$1.51M Sell
20,558
-1,182
-5% -$92.9K 0.29% 74
2019
Q4
$1.89M Sell
21,740
-8,174
-27% -$671K 0.29% 71
2019
Q3
$2.4M Buy
29,914
+350
+1% +$28.1K 0.35% 67
2019
Q2
$2.37M Sell
29,564
-210
-0.7% -$16.1K 0.36% 66
2019
Q1
$2.36M Sell
29,774
-261
-0.9% -$19.5K 0.36% 69
2018
Q4
$2.19M Buy
30,035
+177
+0.6% +$12.5K 0.37% 71
2018
Q3
$2.02M Sell
29,858
-419
-1% -$26.7K 0.3% 74
2018
Q2
$1.75M Sell
30,277
-479
-2% -$27K 0.27% 73
2018
Q1
$1.6M Sell
30,756
-638
-2% -$34.5K 0.27% 72
2017
Q4
$1.69M Buy
31,394
+2,062
+7% +$114K 0.27% 82
2017
Q3
$1.79M Sell
29,332
-573
-2% -$34.7K 0.33% 73
2017
Q2
$1.83M Sell
29,905
-291
-1% -$17.7K 0.34% 73
2017
Q1
$1.83M Buy
30,196
+633
+2% +$38.4K 0.35% 72
2016
Q4
$1.66M Sell
29,563
-681
-2% -$39.9K 0.34% 71
2016
Q3
$1.8M Sell
30,244
-273
-0.9% -$16K 0.39% 64
2016
Q2
$1.68M Sell
30,517
-524
-2% -$27.9K 0.36% 70
2016
Q1
$1.57M Buy
31,041
+661
+2% +$32.4K 0.36% 67
2015
Q4
$1.53M Sell
30,380
-982
-3% -$49.5K 0.36% 70
2015
Q3
$1.48M Buy
31,362
+130
+0.4% +$6.91K 0.37% 75
2015
Q2
$1.7M Sell
31,232
-46
-0.1% -$2.58K 0.46% 56
2015
Q1
$1.72M Hold
31,278
0.47% 58
2014
Q4
$1.7M Sell
31,278
-6,969
-18% -$388K 0.47% 58
2014
Q3
$2.16M Buy
38,247
+233
+0.6% +$13.1K 0.6% 55
2014
Q2
$2.1M Sell
38,014
-105
-0.3% -$5.73K 0.57% 60
2014
Q1
$2.06M Buy
38,119
+302
+0.8% +$15.6K 0.61% 58
2013
Q4
$1.81M Sell
37,817
-83
-0.2% -$3.79K 0.53% 61
2013
Q3
$1.72M Sell
37,900
-105
-0.3% -$4.79K 0.57% 60
2013
Q2
$1.68M Buy
+38,005
New +$1.7M 0.58% 59

Other funds holding MRK

1834 Investment Advisors's MRK Position: Q1 2026 in Review

1834 Investment Advisors increased its Merck (MRK) stake by 2.5% in Q1 2026, buying an estimated $237K and bringing the position to 85,346 shares worth $10.3M. The position accounts for 1.28% of the portfolio, ranked #20.

1834 Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • 1834 Investment Advisors held 85,346 shares of Merck worth $10.3M as of Q1 2026.
  • 1834 Investment Advisors bought 2,051 Merck shares in Q1 2026, an estimated $237K.
  • Merck made up 1.28% of 1834 Investment Advisors's portfolio in Q1 2026, its #20 holding.
  • 1834 Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on 1834 Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.